Luis Sigal, DVM, PhD Receives NIH Funding for R&D of Vaccines & Monoclonal Antibodies for Pandemic Preparedness Network

Dr. Luis Sigal receives funding as part of the National Institutes of Health (NIH) Research & Development of Vaccines & Monoclonal Antibodies for Pandemic Preparedness network

The NIH has established a research network for pandemic preparedness with a focus on multiple “prototypic pathogens”.  Dr. Sigal and colleagues were awarded funding for the Bunyavirus and Picornavirus Pandemic Pathogen Preparedness (BP4) Center, funded by grant: U19 AI181979-01 (PI Crow James. Sigal, LJ Co-investigator).